Natalie S. Haddad

J. Craig Venter Institute — United States

Medicine · Health Sciences

13h-index2.6kcitations54works7.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(24), COVID-19 Clinical Research Studies(17), Long-Term Effects of COVID-19(9), Leprosy Research and Treatment(7), Tuberculosis Research and Epidemiology(5)

Publications54 total

Machine Learning Analysis of Post-Acute COVID Symptoms Identifies Distinct Clusters, Severity Groups, and Trajectories
2025Open Access
Maturation of human early-minted blood antibody-secreting cells is coupled with increased IgG secretion rates
Frontiers in Immunology·2025· 2 citedOpen Access
Mature Human Bone Marrow Plasma Cells Secrete More IgG than Early-Minted Blood Antibody-Secreting Cells
2025Open Access
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
UNC Libraries·2025Open Access
Publisher Correction: Disease-associated B cells and immune endotypes shape adaptive immune responses to SARS-CoV-2 mRNA vaccination in human SLE
Nature Immunology·2024· 3 citedOpen Access
Disease-associated B cells and immune endotypes shape adaptive immune responses to SARS-CoV-2 mRNA vaccination in human SLE
Nature Immunology·2024· 12 citedOpen Access
SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccination
Nature Medicine·2024· 61 citedOpen Access
MENSA, a Media Enriched with Newly Synthesized Antibodies, to Identify SARS-CoV-2 Persistence and Latent Viral Reactivation in Long-COVID
2024Open Access
MENSA, a Media Enriched with Newly Synthesized Antibodies, to Identify SARS-CoV-2 Persistence and Latent Viral Reactivation in Long-COVID
2024· 6 citedOpen Access
Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunity
Journal of Allergy and Clinical Immunology·2024· 15 citedOpen Access
Patients on Benralizumab, Dupilumab, or Mepolizumab Have Lower Post-vaccination SARS-CoV-2 Immunity
2024
The Majority of SARS-CoV-2 Plasma Cells are Excluded from the Bone Marrow Long-Lived Compartment 33 Months after mRNA Vaccination
2024Open Access
The Majority of SARS-CoV-2 Plasma Cells are Excluded from the Bone Marrow Long-Lived Compartment 33 Months after mRNA Vaccination
2024· 3 citedOpen Access
Circulating antibody-secreting cells are a biomarker for early diagnosis in patients with Lyme disease
PLoS ONE·2023· 8 citedOpen Access
Patients on mepolizumab, benralizumab, or dupilumab have diminished post-vaccination antibody and B cell responses to SARS-CoV-2.
2023
Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID
Nature Communications·2023· 124 citedOpen Access
Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti-BAFF/Belimumab treatment
2023· 4 citedOpen Access
Evaluating the Efficacy of Platelet Rich Plasma and 1550 nm Fractional Laser in Combination and Alone for the Management of Androgenetic Alopecia
Journal of Drugs in Dermatology·2022· 10 cited
Dysregulated naive B cells and de novo autoreactivity in severe COVID-19
Nature·2022· 156 citedOpen Access
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
mSphere·2022· 29 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

F. Eun‐Hyung Lee(26), Igñacio Sanz(20), Richard P. Ramonell(16), Fabliha A. Anam(16), John L. Daiss(16), Matthew C. Woodruff(15), Shuya Kyu(15), Andrea Morrison-Porter(15), Doan C. Nguyen(14), Martin Runnstrom(12), John D. Roback(11), Ian Hentenaar(10), Hannah Quehl(9), Kevin S. Cashman(8), Sang Le(8), Monica Cabrera-Mora(7), Hao Wu(7), Ankur Singh Saini(6), Saeyun Lee(6), Scott A. Jenks(6)